Daniel Blake Flora
Impact in
- Oncology top 2%
- COVID-19 and healthcare impacts
- Cancer Immunotherapy and Biomarkers
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
- Oncology 13
- COVID-19 and healthcare impacts 12
- Global Cancer Incidence and Screening 2
-
- Regulation of Appetite and Obesity 2
- Co-authors
- Nguyet Anh Le-Lindqwister (1 shared paper)Paul J. Novotny (1 shared paper)Kathryn J. Ruddy (1 shared paper)Eric G. Wolfe (1 shared paper)Kendrith M. Rowland (1 shared paper)Charles L. Loprinzi (1 shared paper)Roberto Antonio Leon-Ferre (1 shared paper)Thomas J. Smith (1 shared paper)
- Journals
- JAMA Network Open (3 papers)JAMA Oncology (3 papers)Annals of Oncology (2 papers)Cancer Medicine (1 paper)eLife (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Daniel Blake Flora
21 papers receiving 2.3k citations
Daniel Blake Flora's Hit Papers
Peers
Comparison fields: 5 of 111
- Oncology 1.3k
- Infectious Diseases 672
- Endocrine and Autonomic Systems 184
- Internal Medicine 87
- Obstetrics and Gynecology 80
Countries citing papers authored by Daniel Blake Flora
This map shows the geographic impact of Daniel Blake Flora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Blake Flora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Blake Flora more than expected).
Fields of papers citing papers by Daniel Blake Flora
This network shows the impact of papers produced by Daniel Blake Flora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Blake Flora. The network helps show where Daniel Blake Flora may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Blake Flora, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study Hit paper breakdown → | 2020 | 1331 |
| 2 | 2004 | 258 | |
| 3 | 2021 | 234 | |
| 4 | 2021 | 141 | |
| 5 | Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer Hit paper breakdown → | 2023 | 99 |
| 6 | 2019 | 67 | |
| 7 | 2022 | 47 | |
| 8 | 2018 | 37 | |
| 9 | 2022 | 31 | |
| 10 | 2021 | 29 | |
| 11 | 2020 | 26 | |
| 12 | 2020 | 17 | |
| 13 | 2004 | 17 | |
| 14 | 2025 | 10 | |
| 15 | 2022 | 7 | |
| 16 | 2023 | 3 | |
| 17 | 2026 | 3 | |
| 18 | 2023 | 2 | |
| 19 | 2023 | 2 | |
| 20 | 2024 | 1 |
About Daniel Blake Flora
Daniel Blake Flora is a scholar working on Oncology, Endocrine and Autonomic Systems, Nutrition and Dietetics, Internal Medicine and Economics and Econometrics, having authored 21 papers that have together received 2.4k indexed citations. Recurring topics across this work include COVID-19 and healthcare impacts (12 papers), Biochemical Analysis and Sensing Techniques (2 papers), Global Cancer Incidence and Screening (2 papers), Economic and Financial Impacts of Cancer (2 papers), Regulation of Appetite and Obesity (2 papers), Venous Thromboembolism Diagnosis and Management (1 paper), Pancreatic function and diabetes (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Oncology (1.3k citations), Infectious Diseases (672 citations), Endocrine and Autonomic Systems (184 citations), Internal Medicine (87 citations) and Obstetrics and Gynecology (80 citations). Daniel Blake Flora has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Nguyet Anh Le-Lindqwister, Paul J. Novotny, Kathryn J. Ruddy, Eric G. Wolfe, Kendrith M. Rowland, Charles L. Loprinzi, Roberto Antonio Leon-Ferre, Thomas J. Smith, Stephanie S. Faubion and Christopher S. R. Dakhil. Their work appears in journals such as JAMA Network Open, JAMA Oncology, Annals of Oncology, Cancer Medicine and eLife.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.